Ann Thorac Surg 2005;79:183-184
© 2005 The Society of Thoracic Surgeons
INVITED COMMENTARY
Brian W. Duncan, MD
Pediatric and Congenital Heart Surgery/M41, The Children's Hospital, The Cleveland Clinic Foundation, 9500 Euclid Ave, Cleveland, OH 44195, USA
| The first 20% of the full text of this article appears below. |
Massetti and colleagues report the use of extracorporeal life support (ECLS) for the treatment of adults who suffer cardiac arrest refractory to conventional medical therapy. ECLS had to be discontinued within 24 hours due to brain death or multiorgan failure in the majority of patients (55%) while only 8 patients (20%) survived to hospital discharge. These results are substantially worse than reports of survival rates exceeding 50% when ECLS is used as a resuscitation tool for children [1, 2]. The extended . . . [Full Text of this Article]
Related Article
-
Back from Irreversibility: Extracorporeal Life Support for Prolonged Cardiac Arrest
- Massimo Massetti, Marine Tasle, Olivier Le Page, Ronan Deredec, Gerard Babatasi, Dimitrios Buklas, Sylvain Thuaudet, Pierre Charbonneau, Martial Hamon, Gilles Grollier, Jean Louis Gerard, and André Khayat
Ann. Thorac. Surg. 2005 79: 178-183.
[Abstract]
[Full Text]
[PDF]
Copyright © 2005 by The Society of Thoracic Surgeons.